respiratori
syncyti
viru
rsv
major
caus
sever
diseas
young
children
elderli
immunocompromis
popul
furthermor
rsv
lead
caus
infant
hospit
creat
immens
healthcar
burden
treatment
prevent
current
licens
vaccin
rsv
primari
rsv
infect
cell
respons
crucial
mediat
viral
clearanc
deplet
cell
mice
prior
rsv
challeng
lead
elev
viral
load
also
amelior
morbid
thu
cell
contribut
viral
clearanc
immunopatholog
follow
acut
rsv
infect
rsvspecif
memori
cell
also
contribut
protect
secondari
infect
antibodymedi
deplet
memori
cell
rsvimmun
mice
impair
viral
clearanc
follow
reinfect
compar
nontreat
control
thu
vaccin
elicit
robust
memori
cell
respons
may
help
promot
longliv
immun
rsv
induct
neutral
antibodi
remain
primari
goal
rsv
vaccin
due
clearli
establish
capac
reduc
sever
rsvinduc
diseas
contrast
studi
demonstr
robust
memori
cell
respons
mediat
vaccineenhanc
diseas
follow
rsv
infect
adopt
transfer
activ
effector
rsvspecif
cell
vitro
stimul
cell
line
vitro
propag
cell
clone
lead
enhanc
rsv
clearanc
lung
follow
rsv
challeng
effector
cell
transfer
also
associ
increas
weight
loss
indic
infus
effector
cell
induc
increas
system
diseas
howev
role
memori
cell
provid
protect
rsv
infect
remain
unclear
evalu
capac
memori
cell
mediat
protect
rsv
infect
critic
import
high
neutral
antibodi
titer
alon
insuffici
prevent
rsvinduc
diseas
everi
individu
herein
evalu
protect
capac
memori
cell
rsv
infect
absenc
rsvspecif
cell
memori
antibodi
employ
dendrit
celllisteria
monocytogen
dclm
primeboost
immun
regimen
induc
high
magnitud
rsv
epitopespecif
cell
respons
naiv
mice
similar
primeboost
immun
strategi
shown
elicit
protect
respiratori
virus
includ
influenza
viru
iav
sever
acut
respiratori
syndrom
coronaviru
sarscov
dclm
immun
induc
robust
memori
cell
respons
reduc
viral
titer
follow
rsv
challeng
howev
despit
enhanc
viral
clearanc
immun
mice
experienc
increas
pulmonari
diseas
weight
loss
mortal
exacerb
diseas
mortal
uniqu
context
rsv
infect
immun
mice
protect
challeng
lethal
dose
recombin
iav
express
rsvderiv
cell
epitop
lethal
immunopatholog
observ
immun
mice
caus
rapid
excess
product
memori
cell
airway
studi
reveal
memori
cell
enhanc
rsv
clearanc
similar
viral
infect
uniqu
mediat
sever
immunopatholog
caus
overproduct
peptideco
matur
dc
util
prime
cell
respons
allow
robust
secondari
expans
follow
booster
immun
mice
induc
rsvspecif
cell
memori
absenc
virusspecif
cell
antibodi
naiv
mice
immun
matur
splenic
dc
load
peptid
boost
day
later
via
infect
attenu
recombin
lm
strain
express
epitop
control
group
without
rsvspecif
cell
memori
gener
immun
mice
dc
expos
peptid
follow
boost
lm
express
rsvderiv
epitop
dclm
immun
led
signific
p
increas
cell
frequenc
follow
lm
booster
inocul
within
peripher
blood
leukocyt
pbl
compart
compar
control
group
fig
approxim
cell
pbl
day
postboost
fig
immun
mice
challeng
rsv
exhibit
signific
p
reduct
lung
viral
titer
day
postinfect
pi
compar
control
group
undergo
primari
rsv
infect
fig
expect
immun
mice
exhibit
increas
number
total
cell
lung
day
pi
compar
noninfect
control
fig
addit
greater
frequenc
p
cell
follow
peptid
restimul
day
pi
compar
control
group
fig
thu
dclm
immun
elicit
robust
memori
cell
respons
mediat
enhanc
viral
clearanc
follow
rsv
challeng
preexist
memori
cell
alter
respons
specif
cell
type
follow
rsv
infect
fig
convent
regulatori
cell
treg
number
significantli
reduc
p
day
pi
lung
compar
acut
infect
control
group
furthermor
number
monocyt
significantli
p
increas
day
pi
compar
control
mice
chang
contrast
eosinophil
neutrophil
natur
killer
nk
cell
respons
remain
similar
noninfect
mice
overal
dclm
immun
induc
memori
cell
alter
magnitud
subsequ
cellular
infiltr
enhanc
viral
clearanc
follow
rsv
infect
sinc
dclm
immun
mice
exhibit
decreas
viral
titer
next
determin
also
experienc
reduc
diseas
sever
evalu
weight
loss
airway
obstruct
key
diseas
manifest
assess
follow
rsv
infect
mice
despit
enhanc
viral
control
mice
exhibit
signific
p
decreas
surviv
fig
approxim
fatal
due
mice
natur
succumb
rsv
infect
euthan
upon
reach
human
weight
loss
endpoint
outcom
unexpect
unusu
sinc
acut
rsv
infect
rare
fatal
adult
balbc
mice
mice
also
exhibit
significantli
p
increas
weight
loss
fig
reduc
pulmonari
function
fig
addit
evalu
lung
histolog
evid
diffus
alveolar
damag
dad
acut
form
lung
injuri
sever
extens
enough
dad
foundat
lesion
clinic
syndrom
known
acut
respiratori
distress
syndrom
mice
reveal
increas
p
histopatholog
evid
characterist
associ
earli
stage
dad
includ
cellular
slough
necrosi
alveolar
hemorrhag
earli
cellular
infiltr
hyalin
membran
format
fig
fig
previou
work
demonstr
cell
respons
contribut
immunopatholog
associ
acut
rsv
infect
thu
unclear
increas
diseas
sever
observ
mice
uniqu
epitop
address
possibl
evalu
mice
immun
cell
epitop
follow
rsv
infect
similar
mice
dclm
immun
induc
high
frequenc
rsv
memori
cell
mediat
decreas
lung
viral
titer
day
follow
rsv
challeng
fig
addit
mice
exhibit
increas
mortal
weight
loss
pulmonari
dysfunct
compar
control
fig
thu
sever
immunopatholog
induc
memori
cell
specif
either
particular
epitop
rsv
protein
next
determin
rsvspecif
memori
cell
would
also
caus
increas
diseas
mice
acut
rsv
infect
mous
strain
typic
caus
mild
diseas
therefor
immun
mice
immunodomin
cell
epitop
dclm
immun
target
epitop
result
approxim
cell
pbl
day
postboost
fig
similar
balbc
mice
mice
exhibit
significantli
reduc
lung
viru
titer
p
decreas
pulmonari
function
increas
weight
loss
follow
rsv
infect
fig
howev
contrast
balbc
mice
mice
surviv
follow
rsv
infect
data
indic
cell
also
contribut
immunopathogen
respons
genet
background
challeng
viru
util
studi
rsv
strain
primarili
induc
immun
respons
howev
rsv
strain
induc
heterogen
th
respons
determin
memori
cell
gener
dclm
vaccin
induc
immunopatholog
independ
rsv
challeng
strain
infect
mice
recombin
rsv
strain
promot
immun
respons
rsv
mice
challeng
exhibit
mortal
weight
loss
pulmonari
dysfunct
ident
mice
challeng
fig
result
indic
memori
cell
induc
immunopatholog
independ
rsv
strain
util
challeng
determin
memori
cell
would
pathogen
outsid
rsv
infect
challeng
mice
recombin
iav
express
epitop
slutter
et
al
recent
use
similar
dclm
primeboost
strategi
elicit
iavspecif
memori
cell
demonstr
protect
subsequ
iav
infect
similar
rsv
challeng
immun
mice
infect
exhibit
signific
increas
number
total
cell
lung
day
pi
fig
infect
also
result
signific
p
increas
monocyt
decreas
eosinophil
compar
noninfect
control
fig
cell
treg
neutrophil
nk
cell
number
significantli
alter
challeng
mice
fig
anticip
control
mice
virusspecif
memori
cell
succumb
lethal
challeng
howev
contrast
signific
p
mortal
observ
mice
follow
rsv
challeng
mice
protect
lethal
infect
fig
preexist
memori
cell
also
prevent
prolong
weight
loss
pulmonari
dysfunct
observ
control
mice
follow
infect
fig
furthermor
weight
loss
pulmonari
dysfunct
follow
rsv
challeng
significantli
p
increas
earli
timepoint
compar
infect
mice
fig
addit
memori
cell
induc
signific
p
reduct
iav
titer
day
day
pi
fig
data
indic
preexist
rsv
memori
cell
mediat
enhanc
clearanc
promot
increas
surviv
mice
prevent
prolong
diseas
confirm
memori
cell
would
also
provid
protect
without
extens
immunopatholog
lower
viral
inoculum
challeng
mice
subleth
dose
similar
lethal
dose
mice
experienc
significantli
p
improv
pulmonari
function
less
weight
loss
compar
control
group
follow
subleth
infect
fig
thu
memori
cell
promot
distinct
pattern
diseas
sever
subleth
lethal
iav
infect
result
indic
lethal
immunopatholog
associ
highmagnitud
memori
cell
respons
uniqu
context
rsv
infect
dclm
immun
strategi
util
studi
induc
high
frequenc
system
cell
memori
result
fatal
immunopatholog
follow
rsv
challeng
hypothes
local
immun
would
promot
larg
popul
antigenspecif
resid
memori
cell
within
lung
would
prevent
immunopatholog
observ
rsv
infect
evalu
effect
local
immun
mice
either
boost
given
system
boost
intraven
iv
given
local
boost
intrans
administr
boost
induc
signific
p
increas
total
number
cell
lung
prior
rsv
challeng
compar
system
boost
fig
next
util
intravascular
stain
determin
local
cell
within
lung
follow
immun
major
cell
lung
mice
either
boost
boost
system
locat
within
pulmonari
vasculatur
fig
contrast
greater
cell
local
within
lung
tissu
mice
result
signific
p
increas
total
number
compar
mice
fig
addit
local
boost
lung
induc
larg
frequenc
rsvspecif
cell
within
lung
tissu
express
repres
canon
marker
resid
memori
cell
contrast
system
immun
fail
elicit
resid
memori
cell
within
lung
tissu
fig
determin
whether
rsvspecif
resid
memori
cell
gener
local
immun
induc
less
sever
immunopatholog
system
induc
counterpart
mice
either
boost
boost
either
iv
challeng
rsv
monitor
morbid
mortal
contrast
system
boost
local
boost
lung
result
surviv
follow
rsv
challeng
fig
boost
also
result
significantli
p
reduc
weight
loss
pulmonari
dysfunct
follow
rsv
infect
compar
boost
fig
result
suggest
local
primeboost
immun
gener
rsvspecif
resid
memori
cell
prevent
fatal
immunopatholog
amelior
diseas
follow
rsv
challeng
next
evalu
primari
antivir
effector
function
memori
cell
determin
contribut
immunopatholog
primari
pathway
cellmedi
cytolysi
releas
perforin
granzym
therefor
evalu
surviv
diseas
sever
follow
rsv
infect
perforindefici
mice
mice
defici
perforin
exhibit
acceler
mortal
compar
wildtyp
wt
control
fig
kinet
weight
loss
pulmonari
dysfunct
similar
wt
perforindefici
mice
follow
rsv
challeng
fig
therefor
perforin
requir
mediat
exacerb
diseas
may
necessari
prevent
addit
mortal
also
evalu
role
tnf
immun
mice
given
previous
identifi
contribut
immunopatholog
associ
acut
rsv
infect
antibodymedi
neutral
tnf
airway
time
rsv
challeng
led
surviv
mice
fig
neutral
tnf
significantli
p
reduc
weight
loss
pulmonari
dysfunct
fig
data
illustr
similar
acut
rsv
infect
tnf
also
contribut
immunopatholog
associ
memori
cell
respons
furthermor
tnf
neutral
signific
impact
viral
titer
day
pi
fig
assess
tnf
level
day
follow
rsv
challeng
reveal
similar
level
control
mice
fig
tnf
level
lung
significantli
p
increas
mice
day
pi
compar
control
group
increas
observ
serum
fig
howev
overal
amount
tnf
lung
serum
decreas
day
pi
time
immun
mice
began
succumb
rsv
infect
therefor
data
demonstr
tnf
contribut
gener
inflamm
lung
primari
recal
respons
rsv
infect
tnf
necessari
lethal
immunopatholog
occur
due
acceler
memori
cell
respons
dclm
immun
mice
specul
earli
inflammatori
cytokin
milieu
would
distinct
acut
rsv
infect
initi
evalu
level
common
proinflammatori
cytokin
produc
cell
follow
viral
infect
protein
level
significantli
p
increas
lung
serum
day
pi
mice
compar
control
group
fig
level
mice
remain
elev
control
day
pi
overal
amount
reduc
compar
day
follow
infect
interestingli
challeng
result
significantli
p
greater
protein
level
lung
day
day
pi
compar
challeng
rsv
fig
contrast
serum
lung
tnf
level
mice
reduc
p
day
increas
p
day
pi
compar
level
observ
follow
rsv
challeng
fig
determin
vivo
sourc
rsvinfect
immun
mice
treat
mice
brefeldin
bfa
captur
cell
produc
via
intracellular
stain
flow
cytometri
leukocyt
produc
vivo
readili
identifi
use
previous
establish
method
fig
upon
evalu
primari
leukocyt
popul
present
lung
follow
rsv
infect
lymphocyt
produc
immun
mice
day
pi
fig
small
frequenc
cell
nk
cell
secret
observ
day
pi
wherea
approxim
cell
produc
fig
data
also
correl
rapid
transient
increas
amount
protein
observ
lung
serum
day
pi
virtual
cell
recov
day
pi
fig
secret
cell
larg
indic
major
antigenexperienc
cell
fig
compar
lymphocyt
cell
lung
day
pi
half
cell
produc
wherea
almost
remain
cell
also
produc
fig
result
indic
bystand
antigenexperienc
cell
secret
immun
mice
earli
follow
rsv
infect
lastli
assess
product
cell
respiratori
tract
lung
bal
mediastin
lymph
node
mln
peripheri
spleen
pbl
major
cell
secret
local
lung
bal
fig
contrast
rel
low
frequenc
cell
produc
spleen
pbl
virtual
product
observ
mln
fig
taken
togeth
data
demonstr
antigenexperienc
cell
airway
immun
mice
secret
earli
follow
rsv
infect
lead
increas
level
lung
peripheri
due
increas
system
level
larg
produc
antigenexperienc
cell
respiratori
tract
next
determin
necessari
mediat
sever
immunopatholog
immun
mice
evalu
role
treat
mice
either
control
igg
neutral
antibodi
administ
time
rsv
challeng
high
mortal
observ
iggtreat
group
neutral
led
surviv
immun
mice
fig
addit
weight
loss
respiratori
dysfunct
significantli
p
reduc
immun
mice
follow
neutral
compar
iggtreat
mice
fig
neutral
significantli
impact
viru
titer
lung
day
pi
suggest
contribut
pathogen
clearanc
primeboost
immun
model
fig
neutral
result
significantli
p
decreas
tnf
level
lung
day
pi
compar
iggtreat
control
fig
overal
result
suggest
antigenexperienc
cell
rapidli
secret
mediat
lethal
immunopatholog
follow
rsv
infect
dclmimmun
mice
promot
product
tnf
cell
popul
current
rsv
vaccin
develop
assess
focus
upon
induct
strong
humor
immun
respons
contrast
capac
cellular
immun
provid
protect
rsv
infect
receiv
less
attent
evalu
capac
memori
lymphocyt
protect
rsv
infect
result
demonstr
memori
cell
absenc
rsvspecif
cell
memori
antibodi
promot
enhanc
viral
clearanc
follow
rsv
challeng
howev
preexist
rsvspecif
memori
cell
also
mediat
exacerb
diseas
sever
lethal
immunopatholog
cell
respons
previous
shown
contribut
weight
loss
ill
follow
acut
rsv
infect
therefor
cell
respons
play
crucial
role
viral
clearanc
immunopatholog
primari
secondari
respons
number
previou
report
shown
adopt
transfer
activ
effector
rsvspecif
cell
vitro
stimul
cell
line
vitro
propag
cell
clone
result
enhanc
rsv
clearanc
lung
follow
rsv
challeng
effector
cell
transfer
also
associ
increas
weight
loss
indic
infus
effector
cell
lead
induct
increas
system
diseas
thu
studi
contrast
substanti
previou
studi
examin
protect
capac
vivo
gener
rsvspecif
memori
cell
undergon
vitro
activ
restimul
vallbracht
et
al
report
mutat
epitop
sequenc
within
rsv
genom
result
reduc
cellmedi
immunopatholog
follow
acut
infect
howev
enhanc
diseas
sever
associ
preexist
rsvspecif
memori
cell
observ
limit
either
specif
epitop
rsv
protein
dclm
immun
target
either
epitop
result
exacerb
diseas
high
mortal
follow
rsv
challeng
furthermor
immun
immunodomin
epitop
mice
also
caus
increas
weight
loss
pulmonari
dysfunct
mortal
follow
rsv
infect
lack
mortal
immun
mice
may
due
lymphocyt
superior
cytolyt
function
limit
immunopatholog
compar
cell
interestingli
lethal
immunopatholog
associ
preexist
memori
cell
uniqu
context
rsv
infect
memori
cell
protect
exacerb
diseas
sever
respiratori
viral
infect
iav
sarscov
consist
memori
cell
abl
provid
protect
iav
infect
show
rsv
memori
cell
mediat
protect
follow
lethal
infect
system
increas
seen
immun
mice
earli
day
follow
rsv
infect
antigenexperienc
cell
airway
primari
sourc
presenc
cell
airway
suggest
product
respons
antigen
stimul
given
strong
tropism
rsv
epithelium
alveolar
cell
respiratori
tract
interestingli
peak
product
occur
prior
signific
accumul
andor
expans
virusspecif
cell
within
lung
day
pi
observ
similar
work
liu
et
al
show
product
cell
prior
expans
cell
respons
follow
lymphocyt
choriomening
viru
lcmv
infect
neutral
prevent
mortal
reduc
diseas
sever
immun
mice
without
impact
rsv
titer
data
indic
promot
sever
immunopatholog
contribut
viral
clearanc
robust
respons
may
explain
memori
cell
protect
lethal
rsv
infect
antibodymedi
neutral
impact
rsv
viral
titer
acut
infect
indic
minor
role
viral
clearanc
induct
immun
respons
import
prevent
patholog
associ
respons
nonetheless
still
contribut
minim
immunopatholog
associ
acut
rsv
infect
howev
treatment
mice
recombin
earli
timepoint
shown
protect
lethal
iav
infect
differ
viral
clearanc
result
consist
studi
show
dclm
immun
mice
receiv
lethal
iav
infect
significantli
increas
protein
level
lung
earli
time
point
compar
rsv
challeng
mice
togeth
result
suggest
supplement
limit
sever
patholog
associ
lethal
iav
infect
without
contribut
viral
clearanc
therefor
play
distinct
role
either
contribut
immunopatholog
amelior
diseas
depend
upon
respiratori
viru
infect
cell
function
requir
mediat
exacerb
diseas
observ
dclmimmun
mice
immun
mice
defici
perforin
exhibit
similar
diseas
sever
wt
control
follow
rsv
challeng
addit
perforindefici
mice
eventu
succumb
infect
wherea
typic
wt
immun
mice
surviv
previous
demonstr
tnf
level
perforindefici
mice
elev
follow
acut
rsv
infect
like
contribut
acceler
mortal
observ
perforindefici
mice
role
regul
cell
expans
cytokin
product
perforin
prevent
mortal
also
demonstr
secondari
cell
respons
lcmv
lastli
neutral
tnf
also
improv
surviv
amelior
diseas
immun
mice
follow
rsv
infect
cytokin
tnf
known
contribut
weight
loss
inflamm
acut
rsv
infect
therefor
tnf
play
critic
role
mediat
immunopatholog
primari
secondari
rsv
infect
result
contrast
work
lee
et
al
show
enhanc
rsv
clearanc
reduc
diseas
sever
mediat
vaccineelicit
memori
cell
dclm
immun
util
studi
result
dramat
increas
number
rsvspecif
memori
cell
compar
immun
strategi
employ
lee
et
al
dispar
rsvspecif
memori
cell
number
prior
rsv
challeng
may
account
observ
differ
outcom
studi
remain
controversi
whether
strong
cell
respons
desir
rsv
infect
human
experiment
rsv
infect
adult
human
reveal
greater
frequenc
virusspecif
cell
bal
correl
reduc
clinic
diseas
symptom
contrast
greater
ratio
cell
airway
associ
acut
lung
injuri
common
respiratori
tract
infect
rsv
rsvspecif
cell
respons
also
examin
human
follow
rsv
infect
consist
critic
role
clear
acut
infect
studi
weilliv
et
al
found
children
fatal
primari
rsv
infect
fewer
cell
lung
tissu
normal
control
suggest
patient
sever
lower
respiratori
tract
ill
may
insuffici
cellmedi
immun
respons
contrast
report
heidema
et
al
examin
cell
airway
infant
sever
primari
rsv
infect
abl
readili
identifi
rsvspecif
cell
airway
signific
differ
number
recov
infant
versu
less
sever
diseas
thu
current
unclear
cell
contribut
immunopatholog
acut
rsv
infect
infant
role
rsvspecif
memori
cell
human
difficult
address
due
difficulti
obtain
cell
airway
recent
report
jozwik
et
al
use
human
rsv
challeng
model
sought
address
issu
adult
volunt
experiment
infect
rsv
jozwik
et
al
found
higher
baselin
frequenc
rsvspecif
cell
airway
correl
lower
cumul
symptom
score
follow
rsv
challeng
result
obtain
administr
local
boost
consist
notion
data
suggest
system
rsvspecif
memori
cell
prone
caus
immunopatholog
possibl
part
due
delay
reach
lung
howev
use
human
rsv
challeng
model
evalu
protect
capac
memori
cell
absenc
rsvspecif
memori
cell
antibodi
done
use
anim
model
thu
believ
result
applic
human
case
vaccin
rsv
seroneg
individu
would
primarili
elicit
cell
respons
studi
defin
clear
role
memori
cell
follow
rsv
infect
preexist
cell
memori
contribut
enhanc
viral
clearanc
upon
rsv
challeng
also
mediat
sever
immunopatholog
contrast
mani
viral
infect
outcom
compel
given
high
rate
mortal
unusu
rsv
infect
model
data
highlight
complex
uniqu
rsvinduc
immun
respons
contrast
respiratori
viral
infect
result
indic
epitopebas
cellular
vaccin
rsv
may
detriment
consequ
data
also
support
caution
must
exercis
evalu
rsv
vaccin
candid
particularli
robust
memori
cell
respons
involv
order
prevent
induct
immunopatholog
femal
balbcanncr
mice
wk
old
purchas
nation
cancer
institut
frederick
md
femal
perforindefici
mice
provid
dr
john
harti
univers
iowa
iowa
citi
ia
experiment
procedur
util
mice
approv
univers
iowa
anim
care
use
committe
anim
protocol
experi
perform
strict
accord
offic
laboratori
anim
welfar
guidelin
ph
polici
human
care
use
laboratori
anim
memori
cell
induc
use
dclm
primeboost
immun
regimen
balbc
mice
inject
intraperiton
ip
x
melanoma
cell
express
fmsrelat
tyrosin
kinas
ligand
day
mice
inject
iv
lipopolysaccharid
lp
matur
dc
hr
later
spleen
harvest
digest
hbss
contain
uml
dnase
sigmaaldrich
uml
collagenas
invitrogen
gentli
shake
min
spleen
made
singlecel
suspens
incub
concentr
either
peptid
hr
rock
dc
isol
use
microbead
miltenyi
biotec
sort
via
posit
select
automac
separ
miltenyi
biotec
mice
prime
x
peptidepuls
dc
dcimmun
mice
boost
x
actadefici
lm
express
either
administ
iv
day
later
day
follow
lm
boost
mice
infect
either
rsv
control
mice
prime
dc
incub
without
peptid
boost
actadefici
lm
express
rsvderiv
epitop
recombin
lm
strain
creat
use
integr
vector
target
dna
insert
digest
psti
site
ligat
escherichia
coli
cell
recombin
chloramphenicolresist
plasmid
conjug
e
coli
cell
along
strain
lm
resist
streptomycin
brain
heart
infus
agar
plate
growth
previou
step
streak
select
brain
heart
infus
agar
plate
select
chloramphenicol
streptomycinresist
coloni
contain
integr
lm
strain
recombin
lm
grown
tryptic
soy
broth
contain
mgml
streptomycin
strain
rsv
gift
dr
barney
graham
nation
institut
health
bethesda
md
strain
gift
dr
martin
moor
emori
univers
atlanta
ga
rsv
strain
propag
cell
atcc
mice
infect
x
pfu
purifi
rsv
rsv
purif
polyethylen
glycol
ad
crude
rsv
final
dilut
rsv
prepar
mix
hr
centrifug
g
min
swing
bucket
rotor
pellet
resuspend
sucros
solut
place
top
sucros
layer
centrifug
g
hr
purifi
rsv
interfac
sucros
layer
collect
store
solut
creat
buffer
contain
nacl
trishcl
edta
mock
infect
mice
administ
equival
volum
steril
pb
recombin
kindli
provid
dr
ryan
langloi
univers
minnesota
minneapoli
mn
viru
creat
use
standard
revers
genet
previous
describ
rescu
grown
dayold
embryon
chicken
egg
charl
river
epitop
insert
mrna
nucleotid
posit
encod
neuraminidas
stalk
region
known
toler
insert
lethal
heterolog
iav
infect
mice
challeng
dose
repres
x
pfu
recombin
viru
subleth
iav
infect
mice
infect
dose
repres
pfu
certain
experi
mice
boost
given
dose
day
follow
prime
iv
whole
lung
harvest
mice
weigh
mechan
homogen
supernat
store
use
serial
dilut
supernat
perform
incub
vero
cell
atcc
plate
min
plate
overlaid
mixtur
eagl
minimum
essenti
medium
emem
lonza
walkersvil
md
seakem
agaros
cambrex
north
brunswick
nj
follow
day
incub
plate
stain
mixtur
emem
agaros
contain
neutral
red
sigmaaldrich
plaqu
count
hr
determin
iav
titer
lung
process
manner
rsv
plaqu
assay
mdck
atcc
cell
plate
wash
time
room
temperatur
steril
pb
ad
ml
steril
dulbecco
modifi
eagl
medium
afterward
plate
infect
serial
dilut
iavinfect
lung
sampl
dilut
hr
plate
wash
twice
steril
room
temperatur
pb
well
overlaid
ml
mixtur
emem
agaros
contain
mgml
tpcktrypsin
incub
day
agaros
plug
care
remov
monolay
fix
ml
ethanol
min
room
temperatur
monolay
stain
ml
crystal
violet
methanol
min
room
temperatur
plate
wash
pool
warm
water
plate
allow
dri
overnight
plaqu
count
next
morn
pulmonari
function
mice
evalu
use
unrestrain
wholebodi
plethysmographi
enhanc
paus
penh
respiratori
minut
volum
mvb
measur
use
wholebodi
plethysmograph
buxco
electron
wilmington
nc
averag
min
period
weight
loss
track
daili
follow
rsv
iav
infect
mice
mice
start
weight
euthan
tnf
neutral
mice
treat
clone
antitnf
clone
antibodi
rsv
challeng
control
mice
administ
match
dose
control
isotyp
igg
antibodi
whole
lung
harvest
day
follow
rsv
challeng
fix
neutral
buffer
formalin
fisher
scientif
lung
process
previous
describ
stain
h
e
routin
evalu
repres
imag
lung
section
taken
magnif
immun
regimen
tissu
examin
score
manner
mask
experi
group
sampl
assess
evid
dad
histopatholog
earli
stage
dad
includ
alveolar
septal
injuri
cellular
slough
necrosi
hyalin
membran
format
hemorrhag
earli
cellular
infiltr
dad
score
assign
follow
cellular
slough
necrosi
solitari
cell
slough
necrosi
cellular
slough
necrosi
uncommon
septal
wall
hyalin
cellular
slough
necrosi
common
promin
hyalin
membran
serum
collect
whole
lung
harvest
day
pi
lung
disrupt
use
tissu
homogen
ultraturrax
ika
work
inc
wilmington
nc
cell
lysi
buffer
ebiosci
lung
homogen
centrifug
rpm
min
supernat
collect
protein
level
differ
cytokin
chemokin
lung
serum
determin
use
procartaplex
multiplex
immunoassay
kit
ebiosci
accord
manufactur
instruct
assay
run
bioplex
instrument
biorad
hercul
ca
lung
serum
level
determin
elisa
previous
describ
ebiosci
lung
tnf
level
determin
use
mous
tnf
elisa
kit
invitrogen
accord
manufactur
instruct
lung
bal
harvest
mice
previous
describ
spleen
mln
gentli
dissoci
frost
end
microscop
slide
cell
lung
bal
spleen
mln
pbl
stain
extracellular
surfac
molecul
antibodi
specif
clone
siglec
f
bd
bioscienc
clone
clone
clone
clone
clone
clone
clone
clone
clone
clone
clone
clone
clone
min
fix
fixlys
solut
ebiosci
min
room
temperatur
extracellular
stain
cell
stain
ebiosci
clone
transcript
factor
stain
buffer
set
ebiosci
accord
manufactur
instruct
intracellular
cytokin
stain
cell
stimul
hr
peptid
fcssupplement
rpmi
stimul
cell
stain
surfac
marker
indic
stain
intracellularli
antibodi
specif
clone
tnf
clone
fac
buffer
contain
saponin
sigmaaldrich
min
total
number
cytokin
produc
cell
calcul
subtract
background
stain
bfaonli
control
monoclon
antibodi
purchas
biolegend
unless
otherwis
state
stain
cell
run
lsrfortessa
analyz
flowjo
tree
star
ashland
softwar
cell
type
phenotyp
follow
cell
cell
treg
nk
cell
monocyt
eosinophil
neutrophil
siglec
mice
inject
iv
label
fluorescein
isothiocyan
clone
antibodi
min
prior
euthanasia
cell
lung
process
previous
describ
analysi
cell
perform
use
vivo
bfa
administr
mice
inject
iv
bfa
mgml
sigma
pb
lung
bal
spleen
mln
pbl
harvest
hr
later
leukocyt
stain
indic
statist
analys
describ
figur
legend
perform
use
prism
softwar
graphpad
softwar
san
diego
ca
data
evalu
use
unpair
twotail
student
test
two
group
oneway
anova
tukeykram
posttest
analys
two
group
determin
statist
signific
least
asterisk
pound
sign
use
defin
differ
statist
signific
indic
group
respect
control
group
unless
otherwis
indic
line
state
figur
legend
